Cargando…

Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England

Booster vaccination with messenger RNA (mRNA) vaccines has been offered to adults in England starting on 14 September 2021. We used a test-negative case–control design to estimate the relative effectiveness of a booster dose of BNT162b2 (Pfizer-BioNTech) compared to only a two-dose primary course (a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrews, Nick, Stowe, Julia, Kirsebom, Freja, Toffa, Samuel, Sachdeva, Ruchira, Gower, Charlotte, Ramsay, Mary, Lopez Bernal, Jamie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018410/ https://www.ncbi.nlm.nih.gov/pubmed/35045566 http://dx.doi.org/10.1038/s41591-022-01699-1

Ejemplares similares

Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England
por: Kirsebom, Freja Cordelia Møller, et al.
Publicado: (2022)

COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
por: Kirsebom, Freja C M, et al.
Publicado: (2022)

Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England’s experience
por: Tessier, Elise, et al.
Publicado: (2023)

Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England
por: Møller Kirsebom, Freja Cordelia, et al.
Publicado: (2022)

Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study
por: Stowe, Julia, et al.
Publicado: (2022)

Effectiveness of BNT162b2 and ChAdOx-1 vaccines in residents of long-term care facilities in England using a time-varying proportional hazards model
por: Paranthaman, Karthik, et al.
Publicado: (2022)

Effectiveness of BNT162b2 against COVID-19 in adolescents
por: Powell, Annabel A, et al.
Publicado: (2022)

Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
por: Powell, Annabel A, et al.
Publicado: (2023)

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
por: Lopez Bernal, Jamie, et al.
Publicado: (2021)

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2021)

Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2022)

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
por: Andrews, Nick, et al.
Publicado: (2022)

Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England
por: Stowe, Julia, et al.
Publicado: (2023)

All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England
por: Sinnathamby, Mary A, et al.
Publicado: (2020)

Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England
por: Clifford, Samuel, et al.
Publicado: (2023)

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
por: Andrews, Nick, et al.
Publicado: (2022)

Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England
por: Andrews, Nick J, et al.
Publicado: (2021)

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
por: Lopez Bernal, Jamie, et al.
Publicado: (2021)

Variation in COVID-19 booster uptake in England: An ecological study
por: Dropkin, Greg
Publicado: (2022)

Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study
por: Tessier, Elise, et al.
Publicado: (2022)

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
por: Hall, Victoria Jane, et al.
Publicado: (2021)

COVID-19 in children: analysis of the first pandemic peak in England
por: Ladhani, Shamez N, et al.
Publicado: (2020)

Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019
por: Tessier, Elise, et al.
Publicado: (2021)

Nowcasting COVID‐19 deaths in England by age and region
por: Seaman, Shaun R., et al.
Publicado: (2022)

Disease severity during SARS-COV-2 reinfection: a nationwide study
por: Mensah, Anna A., et al.
Publicado: (2022)

Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014–2018
por: Tessier, Elise, et al.
Publicado: (2020)

Effects of COVID-19 Pandemic Response on Service Provision for Sexually Transmitted Infections, HIV, and Viral Hepatitis, England
por: Mitchell, Holly D., et al.
Publicado: (2022)

Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking
por: Graham, Sophie, et al.
Publicado: (2023)

Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters
por: Burckhardt, Rachel M., et al.
Publicado: (2022)

COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study
por: Bertran, Marta, et al.
Publicado: (2022)

Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network
por: Whitaker, Heather, et al.
Publicado: (2022)

Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England
por: Meyer, Carly, et al.
Publicado: (2023)

Evaluation of Risk Factors for Postbooster Omicron COVID-19 Deaths in England
por: Nafilyan, Vahé, et al.
Publicado: (2022)

The association between the proportion of Brexiters and COVID-19 death rates in England()
por: Phalippou, Ludovic, et al.
Publicado: (2023)

Erster COVID-19-Beta-Booster
por: Jahn, Ellen
Publicado: (2023)

Proteinbasierter COVID-19-Booster zugelassen
por: Jahn, Ellen
Publicado: (2023)

Impact of the herpes zoster vaccination programme on hospitalised and general practice consulted herpes zoster in the 5 years after its introduction in England: a population-based study
por: Andrews, Nick, et al.
Publicado: (2020)

Deaths of people with intellectual disabilities: Analysis of deaths in England from COVID‐19 and other causes
por: Heslop, Pauline, et al.
Publicado: (2021)

The impact of social and physical distancing measures on COVID-19 activity in England: findings from a multi-tiered surveillance system
por: Bernal, Jamie Lopez, et al.
Publicado: (2021)

Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design
por: Stowe, Julia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2godc77ml3h3hbn62ujkb50ll8